Related Experiment Video

Updated: Aug 12, 2026

Defining Gene Functions in Tumorigenesis by Ex vivo Ablation of Floxed Alleles in Malignant Peripheral Nerve Sheath Tumor Cells
09:37

Defining Gene Functions in Tumorigenesis by Ex vivo Ablation of Floxed Alleles in Malignant Peripheral Nerve Sheath Tumor Cells

Published on: August 25, 2021

The neurotrophin receptor p75NTR is a tumor suppressor in human prostate cancer

S Krygier1, D Djakiew

  • 1Department of Biochemistry and Molecular Biology, Johns Hopkins School of Hygiene, Baltimore, MD 21205, USA.

Anticancer Research
|March 26, 2002
PubMed

Insights

The neurotrophin receptor p75NTR acts as a tumor suppressor in prostate cancer. Increased p75NTR expression enhances cell cycle quiescence, reduces proliferation, and boosts apoptosis, thereby inhibiting tumor growth.

Area of Science:

  • Oncology
  • Cell Biology
  • Molecular Biology

Background:

  • Loss of tumor suppressor gene function drives prostate cancer progression.
  • Reduced expression of the neurotrophin receptor, p75NTR (p75 neurotrophin receptor), is observed in human prostate tumors.

Purpose of the Study:

  • To investigate the role of p75NTR in prostate tumor suppression.
  • To determine the effect of p75NTR expression on prostate tumor cell behavior in vitro and in vivo.

Main Methods:

  • Cell cycle analysis was performed to assess the impact of p75NTR on prostate tumor cells.
  • Prostate tumor cells with varying p75NTR expression levels were xenografted into SCID mice.
  • Tumor growth, apoptosis (TUNEL assay), and proliferation (PCNA assay) were quantified.

Main Results:

  • Increased p75NTR expression induced dose-dependent cell cycle quiescence in prostate tumor cells.
  • Tumor growth in SCID mice was suppressed proportionally to elevated p75NTR levels.
  • Higher p75NTR expression correlated with increased apoptosis and decreased proliferation.

Conclusions:

  • The neurotrophin receptor p75NTR functions as a prostate tumor suppressor.
  • p75NTR inhibits prostate tumor growth by promoting cell cycle arrest, reducing proliferation, and increasing apoptosis.

More Related Videos

Genetic Profiling and Genome-Scale Dropout Screening to Identify Therapeutic Targets in Mouse Models of Malignant Peripheral Nerve Sheath Tumor09:33

Genetic Profiling and Genome-Scale Dropout Screening to Identify Therapeutic Targets in Mouse Models of Malignant Peripheral Nerve Sheath Tumor

Published on: August 25, 2023

Identifying, Diagnosing, and Grading Malignant Peripheral Nerve Sheath Tumors in Genetically Engineered Mouse Models08:57

Identifying, Diagnosing, and Grading Malignant Peripheral Nerve Sheath Tumors in Genetically Engineered Mouse Models

Published on: May 17, 2024

Related Concept Videos

Enzyme-linked Receptors01:00

Enzyme-linked Receptors

Enzyme-linked receptors are proteins that act as both receptor and enzyme, activating multiple intracellular signals. This is a large group of receptors that include the receptor tyrosine kinase (RTK) family. Many growth factors and hormones bind to and activate the RTKs.
Neurotrophin (NT) receptors are a family of RTKs, including trkA, trkB, and trkC (tropomyosin-related kinase) receptors. TrkA is specific for nerve growth factor (NGF), neurotrophin-6, and neurotrophin-7. TrkB binds...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
The Ras Gene02:38

The Ras Gene

The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a superfamily...
Loss of Tumor Suppressor Gene Functions01:12

Loss of Tumor Suppressor Gene Functions

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
The Retinoblastoma Gene01:20

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...